CN1644184A - Medicinal coating production for vascular stand and electrostatic spraying apparatus - Google Patents
Medicinal coating production for vascular stand and electrostatic spraying apparatus Download PDFInfo
- Publication number
- CN1644184A CN1644184A CNA2005100456689A CN200510045668A CN1644184A CN 1644184 A CN1644184 A CN 1644184A CN A2005100456689 A CNA2005100456689 A CN A2005100456689A CN 200510045668 A CN200510045668 A CN 200510045668A CN 1644184 A CN1644184 A CN 1644184A
- Authority
- CN
- China
- Prior art keywords
- coating
- paint
- pressure pump
- drug
- vascular
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Landscapes
- Media Introduction/Drainage Providing Device (AREA)
- Materials For Medical Uses (AREA)
Abstract
医疗器械领域中的一种血管支架的药物涂层制备方法及其静电喷涂装置,包括:血管支架和药物涂层,特征:制备步骤是:第一步清洗、干燥;第二步将药物和聚合物载体材料混合成涂料,质量比1∶1~1∶100;第三步血管支架接地,涂料经高压泵以0.4~7MPa增压、雾化后形成雾滴,由静电发生器放电而带上电荷,带电雾滴在电场和高压推力的共同作用下,吸附于血管支架表面;第四步干燥和消毒后封装;静电喷涂装置,特征:动力源通过转换阀与高压泵相连,高压泵的吸料阀与涂料容器相连,高压泵的出料阀经蓄压过滤器、涂料输送管到喷枪的喷嘴,喷嘴通过电缆与电压为1~60kv静电发生器相连。优点:表面涂层均匀;厚度可以控制;涂料利用率高;涂层制备的效率高。
A drug coating preparation method for a vascular stent in the field of medical devices and an electrostatic spraying device thereof, comprising: a vascular stent and a drug coating, characterized in that the preparation steps are: the first step is cleaning and drying; the second step is to mix the drug with the polymer Carrier materials are mixed into paint with a mass ratio of 1:1 to 1:100; the third step is grounding of the vascular stent, and the paint is pressurized by a high-pressure pump at 0.4 to 7 MPa and atomized to form mist droplets, which are discharged by an electrostatic generator Electric charge, charged droplets are adsorbed on the surface of the vascular stent under the combined action of the electric field and high-voltage thrust; the fourth step is to dry and sterilize and package; electrostatic spraying device, features: the power source is connected to the high-pressure pump through the switching valve, and the suction of the high-pressure pump The material valve is connected with the paint container, the discharge valve of the high-pressure pump passes through the pressure accumulation filter and the paint delivery pipe to the nozzle of the spray gun, and the nozzle is connected with the electrostatic generator with a voltage of 1-60kv through a cable. Advantages: uniform surface coating; controllable thickness; high utilization rate of coating; high efficiency of coating preparation.
Description
技术领域technical field
本发明涉及到一种血管支架的药物涂层制备方法及其静电喷涂装置,更确切地说,是一种高效的利用静电喷涂制备血管支架的药物涂层方法及其静电喷涂装置,属于医疗器械领域。The present invention relates to a drug coating preparation method for a vascular stent and an electrostatic spraying device thereof, more precisely, an efficient drug coating method for preparing a vascular stent by electrostatic spraying and an electrostatic spraying device thereof, belonging to medical devices field.
背景技术Background technique
1987年,Sigwart(Sigwart U,et al.Intravascular stents to preventocclusion and restenosis after transluminal angioplasty.N Engl J Med,1987,316:701)等首次将冠状动脉血管支架植入人体,为治疗冠心病提供了很好的途径。但是,血管支架植入引起支架内再狭窄在很大程度上限制了它的疗效。再狭窄的原因是血管经支架扩张后造成血管损伤,从而诱导血管平滑肌细胞过渡增殖并向内膜迁移从而造成血管再狭窄的发生。心血管药理学研究发现,多种药物可在体外对血管内膜和平滑肌细胞产生明显的抑制作用,但全身用药却效果不佳,其原因可能与体循环血药浓度过低有关。而通过药物涂层支架将有效药物运至血管损伤处,将有利于并发症的治疗。In 1987, Sigwart (Sigwart U, et al. Intravascular stents to preventocclusion and restenosis after transluminal angioplasty. N Engl J Med, 1987, 316: 701) etc. implanted coronary artery stents into the human body for the first time, providing a great deal for the treatment of coronary heart disease. good way. However, in-stent restenosis caused by vascular stent implantation largely limits its curative effect. The cause of restenosis is that blood vessels are damaged after being expanded by stents, which induces excessive proliferation of vascular smooth muscle cells and migrates to the intima, resulting in vascular restenosis. Cardiovascular pharmacology studies have found that a variety of drugs can produce significant inhibitory effects on vascular intima and smooth muscle cells in vitro, but the effect of systemic drugs is not good. The reason may be related to the low blood drug concentration in the systemic circulation. The delivery of effective drugs to vascular injuries through drug-coated stents will be beneficial to the treatment of complications.
目前,药物涂层血管支架在国内外临床上都已开始使用。例如,U.S.Pat.No.6,099,562,U.S.Pat.No.5,879,697,U.S.Pat.No.5,092,877和U.S.Pat.No.5,304,121等。At present, drug-coated vascular stents have been used clinically at home and abroad. For example, U.S. Pat. No. 6,099,562, U.S. Pat. No. 5,879,697, U.S. Pat. No. 5,092,877 and U.S. Pat. No. 5,304,121 and the like.
血管支架的药物涂层制备方法主要是浸涂和喷涂两大类。喷涂由于其显著的优点——效率高、涂层的量可以控制而被广泛使用。但是,由于血管支架是细小网眼结构,传统的喷涂技术通常存在无法喷到的死角,使血管支架的内外表面涂层很难均匀,例如U.S.Pat.Nos.4,655,771和4,954,126,血管支架管状结构的内表面涂层就比外表面涂层薄。另外,传统的喷涂方法涂料利用率非常低,实际上,传统的喷涂方法只有5%的涂料溶液喷在了支架表面,而其余的绝大部分都浪费了。The drug coating preparation methods of vascular stents mainly fall into two categories: dip coating and spray coating. Spraying is widely used due to its remarkable advantages—high efficiency and controllable amount of coating. However, due to the fine mesh structure of the vascular stent, the traditional spraying technology usually has dead angles that cannot be sprayed, making it difficult to coat the inner and outer surfaces of the vascular stent uniformly, such as U.S. Pat. Nos. The surface coating is thinner than the outer surface coating. In addition, the paint utilization rate of the traditional spraying method is very low. In fact, only 5% of the paint solution is sprayed on the surface of the bracket in the traditional spraying method, and most of the rest is wasted.
另外一种喷涂技术就是静电喷涂。传统的静电喷涂方法是将医疗器械的表面接地,压缩空气以很高的流速从喷枪的喷嘴流过,使喷嘴周围形成局部真空,当涂料被压缩空气的气流吸上来,喷入该真空空间时,被高速气流雾化,形成雾滴,雾滴经过与高压电源相连的喷涂装置后带电,喷涂装置的喷嘴与接地的支架表面形成静电场,带电的雾滴在静电场的作用下沉积在医疗器械表面。例如,U.S.Pat.Nos,5,824,049和6,096,070中所述的采用静电喷涂的方法在医疗器械表面制备生物活性材料。这种传统静电喷涂技术的缺点是:气体的压力很难控制,要想在医疗器械表面得到均匀的涂层,损失大量的涂料是不可避免的。而U.S.Pat.No.6,669,980中提及的一种改进的静电喷涂方法(Method forspray-coating medical devices),该法也是将医疗器械的表面接地,但是涂料的雾化是由单纯的静电完成,也就是涂料在受到高压静电场的作用,涂料液滴被分裂成细小的雾滴,施加的电压越高,电场的裂化作用越强,静电雾化的效果越好。这种方法存在的缺点是:①涂料单纯由静电雾化,很难实现涂料的完全雾化,涂料雾化率低;②由于雾滴间的静电斥力,在血管支架表面只能形成一层薄层,难以达到药物涂层厚度的需求;③涂层的形成完全靠静电的吸附,雾滴到达血管支架的表面速度极慢,降低了涂层制备的效率。Another spraying technique is electrostatic spraying. The traditional electrostatic spraying method is to ground the surface of the medical device, and the compressed air flows through the nozzle of the spray gun at a high flow rate to form a partial vacuum around the nozzle. When the paint is sucked up by the compressed air flow and sprayed into the vacuum space , is atomized by high-speed airflow to form mist droplets, which are charged after passing through the spraying device connected to the high-voltage power supply. The nozzle of the spraying device and the surface of the grounded support form an electrostatic field, and the charged mist droplets are deposited on the medical instrument surface. For example, U.S. Pat. Nos, 5,824,049 and 6,096,070 describe the preparation of bioactive materials on the surface of medical devices by electrostatic spraying. The disadvantage of this traditional electrostatic spraying technology is that the pressure of the gas is difficult to control, and it is inevitable to lose a large amount of paint in order to obtain a uniform coating on the surface of the medical device. An improved electrostatic spraying method (Method forspray-coating medical devices) mentioned in U.S.Pat.No. 6,669,980 also grounds the surface of the medical device, but the atomization of the coating is completed by pure static electricity. That is, the paint is subjected to the action of a high-voltage electrostatic field, and the paint droplets are split into fine mist droplets. The higher the applied voltage, the stronger the cracking effect of the electric field, and the better the effect of electrostatic atomization. The disadvantages of this method are: ①The coating is purely electrostatically atomized, it is difficult to achieve complete atomization of the coating, and the atomization rate of the coating is low; ②Due to the electrostatic repulsion between the droplets, only a thin layer can be formed on the surface of the stent. layer, it is difficult to meet the requirements of the thickness of the drug coating; ③The formation of the coating depends entirely on electrostatic adsorption, and the speed at which the mist reaches the surface of the vascular stent is extremely slow, which reduces the efficiency of coating preparation.
因此,需要一种血管支架的药物涂层制备方法,该方法使得血管支架表面涂层均匀,厚度可以控制且能达到要求,涂料利用率高,涂层制备的效率高。Therefore, there is a need for a drug coating preparation method for vascular stents, the method makes the surface coating of vascular stents uniform, the thickness can be controlled and can meet the requirements, the coating utilization rate is high, and the coating preparation efficiency is high.
发明内容Contents of the invention
本发明的目的和任务是要克服现有技术存在的:①涂料雾化率低;②涂层厚度达不到要求;③涂层制备效率低的不足,并提供一种涂层均匀,厚度可以达到使用要求,涂料的雾化率和利用率高,涂层制备效率高的血管支架的药物涂层制备方法及其静电喷涂装置,特提出本发明的技术解决方案。Purpose and task of the present invention are to overcome prior art existence: 1. coating atomization rate is low; 2. coating thickness does not meet requirement; The technical solution of the present invention is specially proposed for the drug coating preparation method and electrostatic spraying device of the blood vessel stent that meet the use requirements, have high atomization rate and utilization rate of the coating, and have high coating preparation efficiency.
本发明的技术构思是利用高压泵将涂料增大压力,增压后的涂料从喷嘴急速喷出,瞬间降压,剧烈膨胀雾化成极细小的雾滴,并由静电发生器放电而带上电荷,在电场引力和高压推力的共同作用下,吸附于血管支架表面。The technical idea of the present invention is to use a high-pressure pump to increase the pressure of the paint, the pressurized paint is sprayed out from the nozzle rapidly, the pressure is reduced instantaneously, the violent expansion is atomized into very fine mist droplets, and the electrostatic generator is discharged to be charged. , under the combined action of electric field attraction and high-voltage thrust, it is adsorbed on the surface of the vascular stent.
本发明提供一种血管支架的药物涂层制备方法,主要包括:血管支架[2]和由聚合物载体材料及其溶剂和药物混合的涂料[5],通过静电喷涂方法制备的药物涂层,其聚合物载体材料有聚丙交酯(PLA)、聚己内酯(PCL)、聚(丙交酯-乙交酯)(PLGA)、聚(丙交酯-己内酯)(PGA)或聚(丙交酯-乙交酯-己内酯)(PGLC)无规或嵌段共聚物;溶剂有三氯甲烷、二氯甲烷、丙酮、四氢呋喃和二氧六环;药物有雷帕霉素、紫杉醇、肝素、环饱素A、更生霉素、地塞米松、血小板受体抗剂、中药抗增生、抗凝血药物,其特征在于:静电喷涂时,还通过高压泵[7]对涂料[5]施加增压卸压喷涂,压力为0.4~7MPa;涂层制备的步骤是:The invention provides a method for preparing a drug coating of a vascular stent, mainly comprising: a vascular stent [2] and a coating [5] mixed with a polymer carrier material and its solvent and a drug, and a drug coating prepared by an electrostatic spraying method, Its polymer carrier materials are polylactide (PLA), polycaprolactone (PCL), poly(lactide-glycolide) (PLGA), poly(lactide-caprolactone) (PGA) or poly (Lactide-glycolide-caprolactone) (PGLC) random or block copolymer; solvents include chloroform, methylene chloride, acetone, tetrahydrofuran, and dioxane; drugs include rapamycin, paclitaxel , heparin, cyclosporin A, dactinomycin, dexamethasone, anti-platelet receptors, traditional Chinese medicine anti-proliferation, anti-coagulant drugs, characterized in that: during electrostatic spraying, the high-pressure pump [7] is also used for coating [5 ] apply pressurized pressure relief spraying, the pressure is 0.4 ~ 7MPa; the steps of coating preparation are:
第一步,血管支架的清洗The first step, cleaning of vascular stent
将自膨胀血管支架或球囊扩张血管支架分别置于丙酮、乙醇和蒸馏水中超声震荡清洗15~20分钟;在真空干燥箱中60~80℃干燥20~30分钟;Place the self-expandable vascular stent or the balloon-expandable vascular stent in acetone, ethanol and distilled water for ultrasonic vibration cleaning for 15-20 minutes; dry in a vacuum drying oven at 60-80°C for 20-30 minutes;
第二步,涂料的配制The second step, the preparation of paint
在室温下,将聚合物载体材料与其溶剂混合溶解形成均匀溶液,浓度范围1%~15%,再将药物溶解在上述溶液中配制成涂料,药物与聚合物载体材料的质量比是1∶1~1∶100;At room temperature, the polymer carrier material and its solvent are mixed and dissolved to form a uniform solution with a concentration range of 1% to 15%, and then the drug is dissolved in the above solution to prepare a coating. The mass ratio of the drug to the polymer carrier material is 1:1 ~1:100;
第三步,药物涂层的制备The third step, the preparation of the drug coating
采用一个或多个血管支架串联,血管支架的间距是2~5cm,再经导线接地成电中性;将配制好的涂料注入静电喷涂装置[4]的涂料容器中,涂料容器[6]与高压泵[7]相连,高压泵将涂料增压,增压后的涂料经涂料输送管[8]送至喷枪的喷嘴[10]处,涂料从与静电发生器相连的喷嘴急速喷出,瞬间降压,剧烈膨胀雾化成极细小的雾滴[13],并由静电发生器放电而带上电荷,在喷嘴与血管支架之间形成静电场,二者间的距离是1~20cm,带电涂料在电场引力和高压推力的共同作用下,吸附于血管支架内外表面上,并形成一层均匀的涂层,喷涂的时间为5~30秒,涂层的厚度为1~100μm;One or more vascular stents are used in series, the distance between vascular stents is 2-5cm, and then grounded by wires to become electrically neutral; inject the prepared paint into the paint container of the electrostatic spraying device [4], and the paint container [6] and The high-pressure pump [7] is connected, and the high-pressure pump pressurizes the paint, and the pressurized paint is sent to the nozzle [10] of the spray gun through the paint delivery pipe [8], and the paint is sprayed out rapidly from the nozzle connected to the electrostatic generator. Step down, violently expand and atomize into very fine mist droplets [13], and be charged by the discharge of the electrostatic generator, forming an electrostatic field between the nozzle and the vascular stent, the distance between the two is 1-20cm, and the charged paint Under the joint action of electric field attraction and high-voltage thrust, it is adsorbed on the inner and outer surfaces of the stent and forms a uniform coating. The spraying time is 5-30 seconds, and the thickness of the coating is 1-100 μm;
第四步,药物涂层干燥和消毒The fourth step, drug coating drying and disinfection
血管支架的药物涂层制备完毕后置于真空干燥箱中,30~40℃干燥48小时,并用环氧乙烷消毒后封装。After the drug coating of the stent is prepared, it is placed in a vacuum drying oven, dried at 30-40° C. for 48 hours, sterilized with ethylene oxide, and packaged.
本发明提供一种血管支架的药物涂层制备方法的进一步特征在于:涂料[5]中的药物采用一种或几种复配使用。The present invention provides a method for preparing a drug coating for vascular stents, which is further characterized in that: the drugs in the coating [5] are used in combination of one or more.
本发明提供一种血管支架的药物涂层制备方法的静电喷涂装置,主要包括:喷枪[9]、喷嘴[10]、涂料容器[6]、静电发生器[11]和电缆[12],其特征在于:在静电喷涂装置[4]中,还设有通过动力源[14]而工作的高压泵[7],其喷枪[9]是通过高压泵[7]与涂料容器[6]相连,高压泵的吸料阀[21]与涂料容器相连,而高压泵的出料阀[20]是通过蓄压过滤器[23]后再经过涂料输送管[8]到喷枪的喷嘴[10],喷嘴通过电缆[12]与电压为1~60kv的静电发生器[11]相连。The present invention provides an electrostatic spraying device for a drug coating preparation method of a vascular stent, mainly comprising: a spray gun [9], a nozzle [10], a paint container [6], an electrostatic generator [11] and a cable [12]. It is characterized in that: in the electrostatic spraying device [4], there is also a high-pressure pump [7] that works through a power source [14], and its spray gun [9] is connected to the paint container [6] through a high-pressure pump [7], The suction valve [21] of the high-pressure pump is connected to the paint container, and the discharge valve [20] of the high-pressure pump passes through the pressure accumulation filter [23] and then passes through the paint delivery pipe [8] to the nozzle [10] of the spray gun. The nozzle is connected with an electrostatic generator [11] with a voltage of 1-60kv through a cable [12].
本发明提供一种血管支架的药物涂层制备方法的静电喷涂装置,其进一步特征在于:高压泵的动力源[14]采用压缩空气源,或油压源,或电源,动力源的压力为0.4~7MPa;高压泵的动力源将动力经转换阀[15]送入到高压泵中,驱动高压泵活塞[18],而推动柱塞[19],给涂料[5]施加增、卸压力变换。The present invention provides an electrostatic spraying device for a drug coating preparation method of a vascular stent, which is further characterized in that: the power source [14] of the high-pressure pump adopts a compressed air source, or an oil pressure source, or a power supply, and the pressure of the power source is 0.4 ~7MPa; the power source of the high-pressure pump sends power to the high-pressure pump through the switching valve [15], drives the high-pressure pump piston [18], and pushes the plunger [19] to apply pressure increase and release pressure changes to the paint [5] .
实施本发明技术方案时,所采用的参数应按下列原则确定:当脑血管支架的尺寸较小,药物涂层的厚度较薄,涂层厚度应取下限,而聚合物载体材料的浓度、药物与聚合物载体材料的质量比、高压泵压力、静电发生器的电压、喷嘴与支架的距离和喷涂的时间均取下限值;当外周血管支架尺寸较大,药物涂层的厚度相对较厚,涂层厚度应取上限,而聚合物载体材料浓度、药物与聚合物载体材料的质量比、高压泵压力、静电发生器的电压、喷嘴与支架的距离和喷涂的时间均去上限值;当冠状动脉血管支架尺寸介于上述两者之间,涂层的厚度也介于上述两者之间,其他技术参数按照本发明给出的中间值;为实现血管支架的功能化,可选择多层涂层。When implementing the technical scheme of the present invention, the parameters adopted should be determined according to the following principles: when the size of the cerebrovascular stent is less, the thickness of the drug coating is thinner, and the coating thickness should take the lower limit, and the concentration of the polymer carrier material, the drug The mass ratio to the polymer carrier material, the pressure of the high-pressure pump, the voltage of the electrostatic generator, the distance between the nozzle and the stent, and the spraying time all take the lower limit; when the size of the peripheral vascular stent is large, the thickness of the drug coating is relatively thick , the coating thickness should take the upper limit, and the polymer carrier material concentration, the mass ratio of the drug to the polymer carrier material, the high pressure pump pressure, the voltage of the electrostatic generator, the distance between the nozzle and the bracket and the spraying time all go to the upper limit; When the size of the coronary artery stent is between the above-mentioned two, the thickness of the coating is also between the above-mentioned two, and other technical parameters are provided according to the intermediate value of the present invention; in order to realize the functionalization of the vascular stent, multiple options can be selected. layer coating.
本发明的主要优点是:①带电的细小雾滴在静电场作用下,沉积在血管支架表面,使得涂层均匀,且涂层的厚度可以控制为1~100μm,已达到使用要求;②涂料雾化并不是单纯由静电完成的,而是通过高压泵和静电的共同作用使涂料雾化完全,涂料雾化率可高达100%,并且,在静电吸附的作用下,涂料的利用率由传统喷涂的5%增加到本发明的70%,涂料的利用率提高了;③雾滴在高压推力和静电引力的共同作用下,增加了沉积在支架表面的速率,完成每个支架涂层制备的时间由单纯静电吸附的240~360秒到本发明的5~30秒,大大提高了工作的效率。The main advantages of the present invention are: ① charged fine droplets are deposited on the surface of the vascular stent under the action of an electrostatic field, so that the coating is uniform, and the thickness of the coating can be controlled to 1-100 μm, which has met the requirements for use; ② paint mist The atomization of the paint is not done purely by static electricity, but through the joint action of the high-pressure pump and static electricity to completely atomize the paint, and the atomization rate of the paint can be as high as 100%. 5% of the present invention is increased to 70% of the present invention, and the utilization rate of coating has improved; 3. under the joint effect of high-voltage thrust and electrostatic attraction, droplet has increased the rate that is deposited on support surface, finishes the time of each support coating preparation From 240 to 360 seconds of pure electrostatic adsorption to 5 to 30 seconds of the present invention, the working efficiency is greatly improved.
附图说明Description of drawings
下面结合附图对本发明的细节做进一步的说明:Below in conjunction with accompanying drawing, the details of the present invention will be further described:
图1是采用本发明得到的血管支架的药物涂层表面形貌图Fig. 1 is the drug coating surface topography diagram of the vascular stent obtained by the present invention
图中的照片是一个正弦波管网式冠状动脉支架,按本发明的方法涂敷药物涂层后,用SZX-12 Olympus体式显微镜放大100倍,观察到的血管支架药物涂层[1]局部表面形貌图。The photo in the figure is a sine wave tube network type coronary artery stent, after coating the drug coating by the method of the present invention, magnify 100 times with SZX-12 Olympus stereoscopic microscope, the observed vascular stent drug coating [1] local Surface topography.
图中还显示,血管支架表面涂层[1]是光滑、均匀的。The figure also shows that the surface coating of the stent [1] is smooth and uniform.
图2采用本发明所提出的静电喷涂装置加压过程中整体结构状态示意图Fig. 2 adopts the schematic diagram of the overall structure state in the pressurization process of the electrostatic spraying device proposed by the present invention
静电喷涂装置[4]包括:高压泵[7]、涂料输送管[8]、喷枪[9]、喷嘴[10]、静电发生器[11]和电缆[12]。The electrostatic spraying device [4] includes: a high-pressure pump [7], a paint delivery pipe [8], a spray gun [9], a nozzle [10], an electrostatic generator [11] and a cable [12].
图中显示,血管支架[2]经导线[3]接地成电中性;涂料[5]盛装在涂料容器[6]中,涂料容器[6]通过高压泵[7]与喷枪[9]相连,涂料[5]由高压泵[7]增压后经涂料输送管[8]到达喷枪[9]的喷嘴[10]处,喷嘴[10]通过电缆[12]与静电发生器[11]相连。The figure shows that the vascular stent [2] is electrically neutral through the wire [3]; the paint [5] is contained in the paint container [6], and the paint container [6] is connected to the spray gun [9] through the high-pressure pump [7] , the paint [5] is pressurized by the high-pressure pump [7] and reaches the nozzle [10] of the spray gun [9] through the paint delivery pipe [8], and the nozzle [10] is connected to the electrostatic generator [11] through the cable [12] .
图中还显示,由动力源[14]发出动力经转换阀[15],转换阀A口[16]进,转换阀B口[17]出,使活塞[18]下降,推动柱塞[19]下降,此时,高压泵的吸料阀[21]关闭,高压泵的出料阀[20]打开,加压后的涂料[5]从高压泵的出料阀进入,从高压涂料出口[22]输出,经蓄压过滤器[23]和涂料输送管[8]到达喷枪[9]的喷嘴[10]处,急速喷出,瞬间降压膨胀雾化成极细小的雾滴[13],并由静电发生器[11]放电而带上电荷,吸附于血管支架[2]内外表面上。细线箭头表示动力源[14]作用使活塞下降时,动力的运动方向;粗线箭头表示在活塞推动下,柱塞[19]向涂料[5]加压的运动方向;虚线箭头表示涂料加压后,将高压泵的出料阀[20]顶起,涂料通过高压涂料出口[22]进入蓄压过滤器[23],再经涂料输送管[8]进入喷枪[9]的方向,虚线框中的结构表示静电喷涂装置[4]。Also shown in the figure, the power sent by the power source [14] passes through the switching valve [15], the switching valve A port [16] enters, and the switching valve B port [17] exits, so that the piston [18] is lowered, and the plunger [19] is pushed. ] drops, at this time, the suction valve [21] of the high-pressure pump is closed, and the discharge valve [20] of the high-pressure pump is opened. 22] output, through the pressure accumulator filter [23] and the paint delivery pipe [8] to the nozzle [10] of the spray gun [9], it is sprayed out rapidly, the pressure is reduced instantaneously and expanded and atomized into very fine mist droplets [13]. And it is charged by the discharge of the electrostatic generator [11], and is adsorbed on the inner and outer surfaces of the vascular stent [2]. Thin arrows indicate the movement direction of power when the power source [14] acts to lower the piston; thick arrows indicate the movement direction of the plunger [19] pressurizing the paint [5] under the push of the piston; After pressure, the discharge valve [20] of the high-pressure pump is jacked up, and the paint enters the pressure accumulation filter [23] through the high-pressure paint outlet [22], and then enters the direction of the spray gun [9] through the paint delivery pipe [8], the dotted line The structure in the box represents the electrostatic spraying setup [4].
图3是图2在卸压过程中整体结构状态示意图Figure 3 is a schematic diagram of the overall structural state in Figure 2 during the pressure relief process
图中显示,由动力源[14]发出动力经转换阀[15],转换阀B口[17]进,转换阀A口[16]出,使活塞[18]上升,带动柱塞[19]上升,此时,高压泵的吸料阀[21]打开,高压泵的出料阀[20]关闭,涂料容器[6]中的涂料[5]从高压泵的吸料阀[21]进入高压泵[7],此时,高压泵的出料阀[20]关闭,没有涂料通过高压涂料出口[22]进入蓄压过滤器[23],再经涂料输送管[8]进入喷枪[9]中,即没有雾滴形成。细线箭头表示动力源[14]作用使活塞上升时,动力的运动方向;粗线箭头表示在活塞带动下,柱塞[19]向上的卸压的运动方向;虚线箭头表示涂料容器中的涂料[5]经高压泵的吸料阀[21]进入高压泵的方向。As shown in the figure, the power sent by the power source [14] passes through the switching valve [15], the switching valve B port [17] enters, and the switching valve A port [16] exits, so that the piston [18] rises and drives the plunger [19] At this time, the suction valve [21] of the high-pressure pump is opened, the discharge valve [20] of the high-pressure pump is closed, and the paint [5] in the paint container [6] enters the high-pressure pump from the suction valve [21] of the high-pressure pump. pump [7], at this time, the discharge valve [20] of the high-pressure pump is closed, and no paint enters the pressure accumulation filter [23] through the high-pressure paint outlet [22], and then enters the spray gun [9] through the paint delivery pipe [8] , that is, no droplets are formed. The thin line arrow indicates the movement direction of the power when the power source [14] acts to make the piston rise; the thick line arrow indicates the upward pressure relief movement direction of the plunger [19] driven by the piston; the dotted line arrow indicates the paint in the paint container [5] Enter the direction of the high-pressure pump through the suction valve [21] of the high-pressure pump.
图4是采用本发明在血管支架上涂覆多层药物涂层的横截面示意图Fig. 4 is the cross-sectional schematic view of coating multi-layer drug coating on vascular stent by adopting the present invention
图中显示,血管支架[2]、血管支架内表面[25]、血管支架外表面[24]、含雷帕酶素的涂层[26]和含肝素的涂层[27],是本发明为实现血管支架功能化,而涂覆多层药物涂层的一个具体实施例。As shown in the figure, the vascular stent [2], the inner surface of the vascular stent [25], the outer surface of the vascular stent [24], the coating containing rapamycin [26] and the coating containing heparin [27] are the In order to realize the functionalization of the vascular stent, a specific embodiment of coating a multi-layer drug coating.
具体实施方式Detailed ways
根据临床病变的需要,确定支架的含药量,进而确定药物和载体的比例和涂层的厚度。According to the needs of clinical lesions, determine the drug content of the stent, and then determine the ratio of drug and carrier and the thickness of the coating.
实施例1Example 1
为满足××医院临床需求,而制备细小尺寸的药物涂层血管支架,采用本发明技术方案,其制备步骤如下:第一步将血管支架分别置于丙酮、乙醇和蒸馏水中超声震荡清洗15分钟,在真空干燥箱中80℃烘干20分钟;第二步配制涂料,药物与聚合物载体的比例为1∶1(质量比),聚合物载体在其溶剂中的浓度为1%,其中药物为紫杉醇、聚合物载体为聚(丙交酯-乙交酯)(PLGA)和溶剂为三氯甲烷;第三步药物涂层的制备,高压泵压力是0.4MPa,静电发生器的电压是1kv,喷嘴与支架的距离为1cm,涂料雾化后,带电雾滴在高压推力和静电引力的共同作用下沉积在支架的表面,喷涂的时间为5秒;第四步药物涂层干燥和消毒血管支架涂层制备完毕后,在真空干燥箱中,30℃干燥48小时,溶剂脱除,药物涂层干燥后用环氧乙烷消毒封装。经JEOL JSM-5600LV扫描电子显微镜观测涂层厚度为1.04μm,且涂层均匀。In order to meet the clinical needs of XX Hospital, and to prepare small-sized drug-coated vascular stents, the technical solution of the present invention is adopted, and the preparation steps are as follows: the first step is to place the vascular stents in acetone, ethanol and distilled water for ultrasonic vibration cleaning for 15 minutes , dried in a vacuum oven at 80°C for 20 minutes; the second step is to prepare the coating, the ratio of the drug to the polymer carrier is 1:1 (mass ratio), and the concentration of the polymer carrier in its solvent is 1%, wherein the drug For paclitaxel, the polymer carrier is poly(lactide-glycolide) (PLGA) and solvent is chloroform; the preparation of the third step drug coating, high pressure pump pressure is 0.4MPa, and the voltage of electrostatic generator is 1kv , the distance between the nozzle and the stent is 1cm. After the paint is atomized, the charged droplets are deposited on the surface of the stent under the joint action of high-voltage thrust and electrostatic attraction. The spraying time is 5 seconds; the fourth step is to dry and sterilize the blood vessel with drug coating After the stent coating is prepared, it is dried in a vacuum drying oven at 30° C. for 48 hours to remove the solvent. After the drug coating is dried, it is sterilized and packaged with ethylene oxide. According to JEOL JSM-5600LV scanning electron microscope, the thickness of the coating is 1.04 μm, and the coating is uniform.
实施例2Example 2
在大连××医院做动物实验需求,而制备的药物洗脱血管支架,其制备步骤如下:第一步选用316L不锈钢球囊扩张血管支架(3.0×20cm)32个,将血管支架分别置于丙酮、乙醇和蒸馏水中超声震荡清洗20分钟,在真空干燥箱中70℃烘干25分钟;第二步配制涂料,药物与聚合物载体的比例为1∶10(质量比),聚合物载体在其溶剂中的浓度为5%,其中药物为雷帕酶素、聚合物载体为聚(丙交酯-乙交酯)(PLGA)和溶剂为四氢呋喃;第三步药物涂层的制备,将32个血管支架分两批,一批16个,每批中每个血管支架串联间距为2cm,高压泵压力是1MPa,静电发生器的电压是25kv,喷嘴与支架的距离为10cm,涂料雾化后,带电雾滴在高压推力和静电引力的共同作用下沉积在支架的表面,喷涂的时间为10秒;第四步药物涂层干燥和消毒血管支架涂层制备完毕后,在真空干燥箱中,35℃干燥48小时,溶剂脱除;第五步将制备好的药物洗脱血管支架预装在球囊传输系统上,用环氧乙烷高温消毒后封装;第六步经JEOL JSM-5600LV扫描电子显微镜观测涂层厚度为10.06μm,后经动物实验检验按本发明制备的药物洗脱血管支架均为合格产品。The drug-eluting vascular stents prepared in Dalian ×× Hospital for animal experiments are as follows: the first step is to select 32 316L stainless steel balloon-expandable vascular stents (3.0×20cm), and place the vascular stents in acetone , ethanol and distilled water for 20 minutes, and dried in a vacuum oven at 70°C for 25 minutes; the second step is to prepare the coating, the ratio of drug to polymer carrier is 1:10 (mass ratio), and the polymer carrier is in the The concentration in the solvent is 5%, wherein the drug is rapamycin, the polymer carrier is poly(lactide-glycolide) (PLGA) and the solvent is tetrahydrofuran; the preparation of the third step drug coating, 32 The vascular stents are divided into two batches, with a batch of 16. In each batch, the distance between each vascular stent in series is 2cm, the pressure of the high-pressure pump is 1MPa, the voltage of the electrostatic generator is 25kv, and the distance between the nozzle and the stent is 10cm. After the paint is atomized, Charged droplets are deposited on the surface of the stent under the joint action of high-voltage thrust and electrostatic attraction, and the spraying time is 10 seconds; the fourth step is to dry and sterilize the drug coating. Dry at ℃ for 48 hours and remove the solvent; the fifth step is to preload the prepared drug-eluting stent on the balloon delivery system, sterilize it with ethylene oxide and package it; the sixth step is to scan the electron through JEOL JSM-5600LV The coating thickness was 10.06 μm observed under a microscope, and the drug-eluting vascular stent prepared according to the present invention was tested by animal experiments to be qualified products.
实施例3Example 3
为治疗外周血管病变,选择NiTi形状记忆合金自膨胀血管支架,共10个其制备步骤如下:将NiTi形状记忆合金自膨胀血管支架分别置于丙酮、乙醇和蒸馏水中超声震荡清洗20分钟,在真空干燥箱中60℃烘干30分钟;第二步配制涂料,药物与聚合物载体的比例为1∶100(质量比),聚合物载体在其溶剂中的浓度为15%,其中药物为雷帕酶素、聚合物载体为聚丙交酯(PLA)和溶剂为二氯甲烷;第三步药物涂层的制备,将10个血管支架串联间距为5cm,高压泵压力是7MPa,静电发生器的电压是60kv,喷嘴与支架的距离为20cm,涂料雾化后,带电雾滴在高压推力和静电引力的共同作用下沉积在支架的表面,喷涂的时间为30秒;第四步药物涂层干燥和消毒血管支架涂层制备完毕后,在真空干燥箱中,40℃干燥48小时,溶剂脱除;第五步将制备好的药物洗脱血管支架用环氧乙烷高温消毒后封装,经JEOL JSM-5600LV扫描电子显微镜观测涂层厚度为99μm被确认为产品合格。For the treatment of peripheral vascular lesions, a NiTi shape memory alloy self-expanding vascular stent was selected, and a total of 10 preparation steps were as follows: the NiTi shape memory alloy self-expanding vascular stent was placed in acetone, ethanol and distilled water for ultrasonic vibration cleaning for 20 minutes. Dry at 60°C for 30 minutes in a drying oven; the second step is to prepare the coating, the ratio of the drug to the polymer carrier is 1:100 (mass ratio), the concentration of the polymer carrier in its solvent is 15%, and the drug is Rapa Enzyme, polymer carrier are polylactide (PLA) and solvent are dichloromethane; The preparation of the 3rd step drug coating, 10 vascular stents are connected in series and the distance is 5cm, the high pressure pump pressure is 7MPa, the voltage of electrostatic generator It is 60kv, and the distance between the nozzle and the bracket is 20cm. After the paint is atomized, the charged droplets are deposited on the surface of the bracket under the combined action of high-voltage thrust and electrostatic attraction. The spraying time is 30 seconds; the fourth step is to dry the drug coating and After the sterilized stent coating is prepared, dry it in a vacuum drying oven at 40°C for 48 hours to remove the solvent; the fifth step is to sterilize the prepared drug-eluting stent with ethylene oxide at high temperature and package it, and pass it through JEOL JSM -5600LV scanning electron microscope observation coating thickness of 99μm is confirmed as a qualified product.
实施例4Example 4
为实现血管支架的功能化,按本发明制备了两层药物洗脱血管支架,其制备步骤如下:第一步选用316L不锈钢球囊扩张血管支架,将血管支架分别置于丙酮、乙醇和蒸馏水中超声震荡清洗20分钟,在真空干燥箱中80℃烘干20分钟;第二步配制涂料,配制了两种涂料,第一种:药物与聚合物载体的比例为1∶50(质量比),聚合物载体在其溶剂中的浓度为10%,其中药物为雷帕酶素、聚合物载体为聚(丙交酯-乙交酯)(PLGA)和溶剂为二氧六环,第二种:药物与聚合物载体的比例为1∶50(质量比),聚合物载体在其溶剂中的浓度为10%,其中药物为肝素、聚合物载体为聚(丙交酯-乙交酯)(PLGA)和溶剂为二氧六环;第三步药物涂层的制备,首先在血管支架上制备含雷帕酶素药物的涂料,高压泵压力是5MPa,静电发生器的电压是40kv,喷嘴与支架的距离为15cm,涂料雾化后,带电雾滴在高压推力和静电引力的共同作用下沉积在支架的表面,喷涂的时间为20秒,然后再喷涂一层含肝素的涂料,工艺参数同上,在涂层[26]表面得到一层均匀涂层[27];第四步药物涂层干燥和消毒血管支架涂层制备完毕后,在真空干燥箱中,40℃干燥48小时,溶剂脱除;第五步将制备好的药物洗脱血管支架预装在球囊传输系统上,用环氧乙烷高温消毒后封装;第六步经JEOL JSM-5600LV扫描电子显微镜观测到内外两层,内层厚度为49.04μm,外层厚度为50.01μm,后被送到北京××医院检验合格。In order to realize the functionalization of the vascular stent, a two-layer drug-eluting vascular stent was prepared according to the present invention. The preparation steps are as follows: the first step is to select a 316L stainless steel balloon-expanded vascular stent, and place the vascular stent in acetone, ethanol and distilled water respectively. Ultrasonic vibration cleaning for 20 minutes, drying in a vacuum drying oven at 80°C for 20 minutes; the second step is to prepare coatings, two coatings are prepared, the first: the ratio of drug to polymer carrier is 1:50 (mass ratio), The concentration of the polymer carrier in its solvent is 10%, wherein the drug is rapamycin, the polymer carrier is poly(lactide-glycolide) (PLGA) and the solvent is dioxane, the second: The ratio of the drug to the polymer carrier is 1:50 (mass ratio), and the concentration of the polymer carrier in its solvent is 10%, wherein the drug is heparin, and the polymer carrier is poly(lactide-glycolide) (PLGA ) and the solvent are dioxane; the preparation of the third step drug coating, first prepare the coating containing rapamycin on the vascular stent, the high pressure pump pressure is 5MPa, the voltage of the electrostatic generator is 40kv, the nozzle and the stent The distance is 15cm. After the paint is atomized, the charged droplets are deposited on the surface of the bracket under the joint action of high-voltage thrust and electrostatic attraction. The spraying time is 20 seconds, and then a layer of heparin-containing paint is sprayed. The process parameters are the same as above. Obtain a layer of uniform coating [27] on the surface of the coating [26]; the fourth step is to dry the drug coating and sterilize the vascular stent coating, dry it in a vacuum drying oven at 40°C for 48 hours, and remove the solvent; In the fifth step, the prepared drug-eluting stent is pre-installed on the balloon delivery system, sterilized with ethylene oxide and packaged; in the sixth step, the inner and outer layers are observed by JEOL JSM-5600LV scanning electron microscope, and the inner layer The thickness was 49.04 μm, and the thickness of the outer layer was 50.01 μm. Afterwards, it was sent to Beijing XX Hospital for inspection.
Claims (4)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100456689A CN100374092C (en) | 2005-01-14 | 2005-01-14 | Preparation method of drug coating for vascular stent and electrostatic spraying device thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100456689A CN100374092C (en) | 2005-01-14 | 2005-01-14 | Preparation method of drug coating for vascular stent and electrostatic spraying device thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1644184A true CN1644184A (en) | 2005-07-27 |
| CN100374092C CN100374092C (en) | 2008-03-12 |
Family
ID=34876389
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100456689A Expired - Fee Related CN100374092C (en) | 2005-01-14 | 2005-01-14 | Preparation method of drug coating for vascular stent and electrostatic spraying device thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100374092C (en) |
Cited By (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100371030C (en) * | 2006-01-20 | 2008-02-27 | 重庆大学 | Drug-eluting intravascular stent spraying method and spraying device |
| CN1799650B (en) * | 2005-12-30 | 2010-07-14 | 李文涛 | Preparation method of biodegradable drug-loaded polymer material scaffold |
| CN101282694B (en) * | 2005-10-05 | 2010-12-15 | 伊西康公司 | Improved method for coating medical devices |
| CN101918051A (en) * | 2007-11-14 | 2010-12-15 | 生物传感器国际集团有限公司 | Automated coating equipment and methods |
| CN102639161A (en) * | 2009-09-29 | 2012-08-15 | 伊西康公司 | Antimicrobial/antibacterial medical devices coated with traditional Chinese medicines |
| CN102639255A (en) * | 2009-08-04 | 2012-08-15 | 艾博特心血管系统公司 | Stent and method of coating same |
| CN102961788A (en) * | 2012-12-04 | 2013-03-13 | 东华大学 | Heparin-loaded covered stent for treating arterial aneurysm and preparation method thereof |
| CN103566418A (en) * | 2013-08-13 | 2014-02-12 | 重庆大学 | Preparation method of multi-coating drug eluting intravascular stent |
| CN103566414A (en) * | 2013-08-13 | 2014-02-12 | 重庆大学 | Nano-microcapsule coated intravascular stent of core-shell structure and preparation method of intravascular stent |
| CN103705981A (en) * | 2013-10-10 | 2014-04-09 | 上海师范大学 | Quick preparation method of growth-factor-loading high-cell-load tissue engineering scaffold |
| CN101337093B (en) * | 2008-08-07 | 2014-04-09 | 乐普(北京)医疗器械股份有限公司 | Preparation method of monoclonal antibody coating biology stand |
| CN104053509A (en) * | 2012-01-23 | 2014-09-17 | 科特罗尼克有限公司 | Device for coating stent, corresponding coating method, and stent produced according to said method |
| CN104607339A (en) * | 2015-01-22 | 2015-05-13 | 上海理工大学 | Medicine spraying Z-axis system |
| CN107485777A (en) * | 2017-09-06 | 2017-12-19 | 乐普(北京)医疗器械股份有限公司 | A kind of preparation method of the controllable medicinal balloon catheter of crystal, the medicinal balloon catheter being prepared and its application |
| CN108309204A (en) * | 2017-01-16 | 2018-07-24 | 深圳市先赞科技有限公司 | Equipped with the endoscope using snake gelatine skin made of spraying process |
| WO2018157783A1 (en) * | 2017-03-02 | 2018-09-07 | 优微(珠海)生物科技有限公司 | Method and device for manufacturing soluble micro-needles |
| CN109793935A (en) * | 2019-01-16 | 2019-05-24 | 武汉杨森生物技术有限公司 | A kind of preparation method of artificial blood vessel material and thus obtained artificial blood vessel and application |
| CN110385327A (en) * | 2019-08-05 | 2019-10-29 | 魏东金 | A kind of nanometer film isolation oil gas inhibits system and nanometer film that oil gas suppressing method is isolated |
| CN115192130A (en) * | 2022-08-09 | 2022-10-18 | 惠州市顺美医疗科技有限公司 | Embolectomy bracket and production manufacturing process thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6743462B1 (en) * | 2001-05-31 | 2004-06-01 | Advanced Cardiovascular Systems, Inc. | Apparatus and method for coating implantable devices |
| US6645547B1 (en) * | 2002-05-02 | 2003-11-11 | Labcoat Ltd. | Stent coating device |
| CN1244314C (en) * | 2002-12-25 | 2006-03-08 | 中国科学院金属研究所 | A kind of coating preparation method of drug-coated cardiovascular stent |
| US7261915B2 (en) * | 2003-04-09 | 2007-08-28 | Boston Scientific Scimed, Inc. | Electrohydrodynamic coating fluid delivery apparatus and method |
-
2005
- 2005-01-14 CN CNB2005100456689A patent/CN100374092C/en not_active Expired - Fee Related
Cited By (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101282694B (en) * | 2005-10-05 | 2010-12-15 | 伊西康公司 | Improved method for coating medical devices |
| CN1799650B (en) * | 2005-12-30 | 2010-07-14 | 李文涛 | Preparation method of biodegradable drug-loaded polymer material scaffold |
| CN100371030C (en) * | 2006-01-20 | 2008-02-27 | 重庆大学 | Drug-eluting intravascular stent spraying method and spraying device |
| US9511385B2 (en) | 2007-11-14 | 2016-12-06 | Biosensors International Group, Ltd. | Automated stent coating apparatus and method |
| CN103480047B (en) * | 2007-11-14 | 2015-02-18 | 生物传感器国际集团有限公司 | Automated coating apparatus and method |
| CN101918051B (en) * | 2007-11-14 | 2013-08-21 | 生物传感器国际集团有限公司 | Automated coating apparatus and method |
| CN101918051A (en) * | 2007-11-14 | 2010-12-15 | 生物传感器国际集团有限公司 | Automated coating equipment and methods |
| US9802216B2 (en) | 2007-11-14 | 2017-10-31 | Biosensors International Group, Ltd. | Automated stent coating apparatus and method |
| CN101337093B (en) * | 2008-08-07 | 2014-04-09 | 乐普(北京)医疗器械股份有限公司 | Preparation method of monoclonal antibody coating biology stand |
| CN102639255A (en) * | 2009-08-04 | 2012-08-15 | 艾博特心血管系统公司 | Stent and method of coating same |
| CN102639255B (en) * | 2009-08-04 | 2015-09-30 | 艾博特心血管系统公司 | Support and painting method thereof |
| CN102639161B (en) * | 2009-09-29 | 2015-07-22 | 伊西康公司 | Antimicrobial/antibacterial medical devices coated with traditional Chinese medicines |
| CN102639161A (en) * | 2009-09-29 | 2012-08-15 | 伊西康公司 | Antimicrobial/antibacterial medical devices coated with traditional Chinese medicines |
| CN104053509B (en) * | 2012-01-23 | 2017-01-18 | 科特罗尼克有限公司 | Device for coating stent, corresponding coating method, and stent produced according to said method |
| CN104053509A (en) * | 2012-01-23 | 2014-09-17 | 科特罗尼克有限公司 | Device for coating stent, corresponding coating method, and stent produced according to said method |
| CN102961788B (en) * | 2012-12-04 | 2015-08-12 | 东华大学 | A kind of heparin load aneurysm treatment overlay film frame and preparation method thereof |
| CN102961788A (en) * | 2012-12-04 | 2013-03-13 | 东华大学 | Heparin-loaded covered stent for treating arterial aneurysm and preparation method thereof |
| CN103566414A (en) * | 2013-08-13 | 2014-02-12 | 重庆大学 | Nano-microcapsule coated intravascular stent of core-shell structure and preparation method of intravascular stent |
| CN103566418A (en) * | 2013-08-13 | 2014-02-12 | 重庆大学 | Preparation method of multi-coating drug eluting intravascular stent |
| CN103566414B (en) * | 2013-08-13 | 2016-01-13 | 重庆大学 | A kind of nucleocapsid structure receives particulate coatings intravascular stent and preparation method thereof |
| CN103566418B (en) * | 2013-08-13 | 2016-01-20 | 重庆大学 | A kind of preparation method of laminated coating drug eluting vascular support |
| CN103705981A (en) * | 2013-10-10 | 2014-04-09 | 上海师范大学 | Quick preparation method of growth-factor-loading high-cell-load tissue engineering scaffold |
| CN103705981B (en) * | 2013-10-10 | 2015-07-22 | 上海师范大学 | Quick preparation method of growth-factor-loading high-cell-load tissue engineering scaffold |
| CN104607339A (en) * | 2015-01-22 | 2015-05-13 | 上海理工大学 | Medicine spraying Z-axis system |
| CN108309204A (en) * | 2017-01-16 | 2018-07-24 | 深圳市先赞科技有限公司 | Equipped with the endoscope using snake gelatine skin made of spraying process |
| WO2018157783A1 (en) * | 2017-03-02 | 2018-09-07 | 优微(珠海)生物科技有限公司 | Method and device for manufacturing soluble micro-needles |
| CN107485777A (en) * | 2017-09-06 | 2017-12-19 | 乐普(北京)医疗器械股份有限公司 | A kind of preparation method of the controllable medicinal balloon catheter of crystal, the medicinal balloon catheter being prepared and its application |
| CN109793935A (en) * | 2019-01-16 | 2019-05-24 | 武汉杨森生物技术有限公司 | A kind of preparation method of artificial blood vessel material and thus obtained artificial blood vessel and application |
| CN109793935B (en) * | 2019-01-16 | 2021-09-03 | 武汉杨森生物技术有限公司 | Preparation method of artificial blood vessel material, artificial blood vessel prepared by preparation method and application of artificial blood vessel material |
| CN110385327A (en) * | 2019-08-05 | 2019-10-29 | 魏东金 | A kind of nanometer film isolation oil gas inhibits system and nanometer film that oil gas suppressing method is isolated |
| CN115192130A (en) * | 2022-08-09 | 2022-10-18 | 惠州市顺美医疗科技有限公司 | Embolectomy bracket and production manufacturing process thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100374092C (en) | 2008-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1644184A (en) | Medicinal coating production for vascular stand and electrostatic spraying apparatus | |
| CN101279111B (en) | Method for preparing blood vessel stent with polyester medicament eluting coating | |
| CN103566414B (en) | A kind of nucleocapsid structure receives particulate coatings intravascular stent and preparation method thereof | |
| CN103566418B (en) | A kind of preparation method of laminated coating drug eluting vascular support | |
| DE602004012597T2 (en) | COATINGS FOR IMPLANTABLE DEVICES CONTAINING BLOCK COPOLYMERS FROM MILKY ACID AND ETHYLENE GLYCOL | |
| US20040030377A1 (en) | Medicated polymer-coated stent assembly | |
| EP1667743B1 (en) | Biocompatible, biostable coating of medical surfaces | |
| CN101785880B (en) | Drug-loaded vascular stents using titanium oxide nanotubes | |
| CA2432159A1 (en) | Medicated polymer-coated stent assembly | |
| CN102083412A (en) | Programmed release of nanostructured bioconstructs for cell implantation for stimulating tissue regeneration | |
| CN101185779A (en) | A kind of preparation method of drug sustained-release stent | |
| WO2009046093A2 (en) | Method and system for coating a surface of a medical device with a therapeutic agent and drug eluting medical devices made thereby | |
| Ghobeira et al. | Plasma surface functionalization of biodegradable electrospun scaffolds for tissue engineering applications | |
| CN110575607B (en) | A drug balloon | |
| CN110180038A (en) | Has the kirsite vascular stent material of drug slow release function superhigh-flexibility coating | |
| US20240216584A1 (en) | Methods, systems, and devices for generating defined fiber constructs | |
| US9056153B2 (en) | Biocompatible polymers for coating or fabricating implantable medical devices | |
| CN1569270A (en) | Method for preparing cardiovascular drug eluting stent | |
| CN101703428B (en) | A kind of blood vessel stent with anti-restenosis coating and preparation method thereof | |
| CN100371032C (en) | Anti-restenosis drug slow-release vascular stent and preparation method thereof | |
| CN114246993B (en) | Composite coating with adjustable active ingredient release performance and preparation method thereof | |
| Frumento et al. | Advanced Coating Strategies for Immunomodulatory Biomaterials for Reconstructive Osteogenesis: Mitigating Foreign Body Reaction and Promoting Tissue Regeneration | |
| CN110404123A (en) | A kind of load medicine small-caliber vascular stent and preparation method thereof | |
| CN1827178A (en) | Drug-eluting intravascular stent spraying method and spraying device | |
| KR20130119727A (en) | Drug eluting stent |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080312 Termination date: 20110114 |